At a glance
ClinicalIndex Comparison RecordN/ACompleted· 334 enrolled
Drug / intervention
Telemedicine group +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Telemedicine on Metabolic Control in the Care of Diabetes Mellitus Type 1 Patients in Multiple Doses of Insulin Treatment in Andalusian Community
Sociedad Andaluza de Endocrinología, Diabetes y Nutrición·interventional·Posted Nov 6, 2017·Updated Nov 6, 2017
In Brief
A clinical study evaluating Telemedicine group and Conventional group for Telemedicine. Completed, enrolled 334 participants across 1 site.
Detailed Summary
To assess the effect of a 6-month telemedicine program (DiabeTIC) in patients with type 1 diabetes mellitus (DM1) and regular metabolic control (HbA1c \<8%) in multi-dose insulin treatment (MDI) measured HbA1c vs. conventional medical care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTelemedicine
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
Primary CompletionNov 2014
Study CompletionDec 2016
First PostedNov 2017
TodayJul 2026
First PostedNov 6, 2017
Enrollment StartDec 1, 2013
Primary CompletionNov 1, 2014
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.7 years ago
Interventions
Telemedicine groupother
Conventional groupother